氨曲南具有免疫原性弱以及青霉素类、头孢菌素类交叉过敏少等特点，因此可用于替代氨基糖苷类药物，治疗肾功能损害患者的需氧革兰阴性菌感染；并可在密切观察情况下用于对青霉素、头孢菌素过敏的患者。
Aztreonam 氨曲南(Azactam), 1 g three times daily Gentamicin 庆大霉素(Garamycin), 3 mg per kg per day in 3 divided doses every 8 hours
基于54个网页-相关网页
一个扁桃体发炎用这两个药胆真氨曲南(AZT )是第一个应用于临床的单环8一内酰胺类抗生素，对革兰氏阴性菌有很强的抗菌活性，对B一氨曲南属单环β-内酰胺类抗生素，是一种杀...
基于42个网页-相关网页
注射用氨曲南 Aztreonam for Injection ; Aztreonam for Inj ; Aztreon ; Azt
氨曲南主环 Amino-2-methyl-4-oxo-1-azetidinesulfonic Acid ; -3-Amino-2-methyl-4-oxo-1-azetidinesulfonic Acid ; Ami ; Amino-2-methyl-4-oxo-1-az
开环氨曲南 Open Ring Aztreonam
氨曲南事件 Aztreonam events
关键词】氨曲南 Key words aztreonam ; cefepime ; lower respiratory tract infections
氨曲南赖氨酸 aztreonam lysine
氨曲南标准品 Aztreonam
开链氨曲南 Open Ring Aztreonam
ResultsThe resistance rate of pseudomonas aeruginosa to ceftriaxone(97.2%) was the highest,followed by cotrimoxazole(72.2%),cefotaxime(62.5%),ceftizoxime (62.5%),tetracycline(62.5%)and aztreonam(51.4%),the resistance rate of 6 antimicrobial drugs reaching 50%.
结果 铜绿假单胞菌的耐药率以头孢曲松(97.2%)为最高,其次为复方新诺明(72.2%)、头孢噻肟(62.5%)、头孢唑肟(62.5%)、四环素(62.5%)、氨曲南(51.4%),有6种抗菌药物的耐药率达到了50%。
参考来源 - 呼吸内科下呼吸道感染铜绿假单胞菌的耐药性分析—《中国现代医生》—2010年第13期—龙源期刊网·2,447,543篇论文数据，部分数据来源于NoteExpress
对氨曲南的药理作用及临床应用作一综述。
A brief summary was made on the clinical pharmacology and application of aztreonam.
在停止吸入氨曲南赖氨酸两周内，观测到的改善状态下降。
The observed improvements declined during the 2 weeks after inhaled aztreonam lysine was stopped.
目的评价氨曲南治疗肿瘤患者下呼吸道感染的成本。效果，促进合理用药，降低医疗费用。
Objective to evaluate the cost-effectiveness of aztreonam in the treatment of cancer patients with lower respiratory tract infection, promote rational use of the drugs and decrease treatment cost.
应用推荐